期刊文献+

和肽素、精氨酸受体mRNA检测在急性冠脉综合征诊治中的临床意义 被引量:5

下载PDF
导出
摘要 目的探讨和肽素、精氨酸受体(AVPR)2 mRNA对急性冠脉综合征(ACS)患者的临床意义。方法采用病例对照研究,选取大连医科大学附属第一医院2013年5月至2014年12月以胸痛为主诉入院患者共154例。ACS组118例,其中不稳定型心绞痛(UAP)44例,急性心肌梗死(AMI)74例;对照组36例。研究对象均进行血脂、肝功、肾功、B型尿钠肽(BNP)、心肌酶、超声心动图、冠状动脉造影检查。分析和肽素及AVPR2mRNA与冠心病不同分型、冠脉病变程度的关系,并探讨其对AMI的诊断价值。结果 1对照组、UA组、AMI组患者和肽素水平三组间两两比较均有统计学差异(P<0.05),且均依次升高。此外,和肽素水平与AVPR2 mRNA水平呈正相关。2ACS患者Gensini评分2、3组和肽素水平及AVPR2mRNA无统计学差异;但ACS患者2、3组比1组的和肽素水平高,3组比1组的AVPR2 mRNA高,均有统计学差异;ACS患者1、2组的AVPR2 mRNA无统计学差异。3左主干病变和肽素水平最高且分别与单支、双支、三支病变组相比,均有统计学差异;三支、双支病变组比较及三支、单支病变组比较均有统计学差异;单支、双支病变组比较无统计学差异。左主干患者的AVPR2 mRNA水平最高且分别与单支、双支、三支病变组比较,均有统计学差异;而单支、双支、三支病变组两两相比较,均无统计学差异。4和肽素、AVPR2 mRNA及c Tn I水平制作ROC曲线下面积分别为0.855(95%CI为0.792,0.918)、0.779(95%CI为0704,0853)、0.964(95%CI为0.936,0.991)。Logistic回归分析和ROC曲线三者联合检测,AVPR2 mRNA水平并未纳入方程,联合和肽素、c Tn I诊断AMI的ROC曲线下面积为0.972(95%可信区间为0.938,0.996)。提示联合肽素及c Tn I检测有望提高AMI的准确性。结论 1和肽素、AVPR2 mRNA随冠心病的进展而升高,能够在一定程度上反应冠脉病变程度。2AVPR2 mRNA水平与和肽素水平呈正相关;联合c Tn I及和肽素检测有望提高AMI诊断的准确性,为AMI的早期诊断提供参考价值。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2016年第6期1329-1332,共4页 Chinese Journal of Gerontology
基金 大连市科技计划项目(No.2013E15SF147)
  • 相关文献

参考文献16

  • 1陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 2Morawice B,Kawecki D.Copeptin:a new marker in cardiology[J].J Cardiovasc Med(Haders-town),2013;14:19-25.
  • 3Morgenthaler NG,Struck J,Alonso C,et al.Assay for the measurement of copeptin a stable peptide derived from the precursor of vasopressin[J].Clin Chemm,2006;52(1):112-9.
  • 4Lemmens-Gruber R,Kamyar M.Vasopressin antagonists[J].Cell Mol Life Sci,2006;63(15):1766-79.
  • 5Khan SQ,Dhillon OS,O'Brien RJ,et al.C-terminal provasopressin(copeptin)as a novel and prognostic marker in acute myocardial infarction:leicester acute myocardial infarction peptide(LAMP)Study[J].Circulation,2007;115(16):2103-10.
  • 6Struck J,Morgenthaler NG,Bergmann A.Copeptin,a stable peptide derived from the vasopressin precursor,is elevated in serum of sepsis patients peptides[J].Clin Chen,2005;26:2500-24.
  • 7Maisel A,Mueiier C,Neath S,et al.Copeptin helps in the early detection of patients with acute myocardial infarction[J].J Am Coll Cardiol,2013;62:150-60.
  • 8Meune C,Zuily S,Wahbi K,et al.Combination of copeptin and high sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction:a pilot study[J].Arch Cardiovasc Dis,2011;104:4-10.
  • 9Charpencier S,Maupas-Schwalm F,Cournot M,et al.Combination of copeptin and troponin assays to rapidly rule out non-ST-elevation myocardial infarction in the emergency department[J].Acad Emery Med,2012;19:517-24.
  • 10Balmell C,Meune C,Twerenbold R,et al.Comparison of the performances of cardiac troponins,including sensitive as says,and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men[J].A Heart J,2013;116:30-7.

二级参考文献6

  • 1KELLER T, TZIKAS S, ZELLER T. et al. Copep tin improves early diagnosis of acute myocardial in- farction[J]. J Am Coil Cardiol,2010,55:2096-2106.
  • 2MEUNE C, ZUILY S, WAHBI K. et al. Combina- lion of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment eleva tion myocardial infarction: a pilot study[J]. Arch Cardiovasc Dis, 2011,104 .. 4- 10.
  • 3REICHLIN T, HOCHHO1.ZER W, STELZIG C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction[J]. J Am Coil Cardiol, 2009,54:60-68.
  • 4KHAN S Q, DHILLON Q S, O'BRIEN R J, et al. Gter minal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute My- ocardial Infarction Peptide (LAMP) study[J]. Circulation, 2007,115 : 2103- 2110.
  • 5VOORS A A, VON HAEHLING S, ANKER S D, et al. C-terminal provasopressin (copeptin) is a strong prognostic marker iil patients with hear failure after an acute myocardial infarction: results from the OPTI- MAAL study[J]. Eur Heart J,2009,30:1187-1194.
  • 6闫小菊,刘松,黄玉晓.血浆和肽素与急性心肌梗死患者近期预后的关系[J].临床心血管病杂志,2011,27(9):680-682. 被引量:12

共引文献1696

同被引文献28

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部